Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Nonparametric one-way ANOVA analysis performed; *p ≤ 0.05, **p ≤ 0.01, and ****p ≤ 0.0001. Scale Bar = 20 μm.…”

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

Subjects:

Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

Subjects:

Decreased expression levels of SPI-1 genes in <i>bipA</i>-deleted strain at 20°C. by Eunsil Choi (8271039)

Subjects:

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

Phosphosite mutations in Hcm1 decrease fitness in stress. by Michelle M. Conti (13514386)

Type IV pili decreases in ARC6851 under colistin and diclofenac combination treatment. by Fabiana Bisaro (20308955)

PBP1 depletion results in a population of cells with decreased RADA fluorescence. by Gregory A. Harrison (16639446)

“…The mean RADA fluorescence was quantified for each cell using SuperSegger. A histogram depicting the percent of cells with the indicated amount of RADA fluorescence reveals that PBP1 depletion results in a population with decreased RADA signal. …”

Uncropped blots corresponding to Fig 3A, provided for assessment of band specificity and loading consistency. by Tetsuya Kakita (4922584)

Subjects:

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

Expression of a phosphomimetic Hcm1 mutant decreases fitness in LiCl stress. by Michelle M. Conti (13514386)

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Decreased cytokine expression in J2.2-HKU1.7b-infected BMDM. by Chaminda D. Gunawardene (22794593)

Hypothetical model representing the distinct strategies of epithelial barrier disruption by Oki strains. by Tetsuya Kakita (4922584)

Subjects:

<i>L.</i><i>interrogans</i> induces afadin degradation in infected RPTECs through different strain-dependent mechanisms. by Tetsuya Kakita (4922584)

Subjects:

Proteosomal and pan-caspase inhibitors differentially prevent the disruption of the epithelial cell barrier by the clinical <i>Leptospira</i> isolates. by Tetsuya Kakita (4922584)

Subjects:

Immunofluorescence analysis using dual staining for E-cadherin (E-cad) and afadin and F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

Subjects:

Immunofluorescence analysis for F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

Subjects: